Healthcare Additive Manufacturing Market Trends

Healthcare Additive Manufacturing Market size was valued at USD 7.4 Billion in 2023 and is poised to grow from USD 8.74 Billion in 2024 to USD 33.09 Billion by 2032, growing at a CAGR of 18.1% during the forecast period (2025-2032).

Key companies use mergers, acquisitions, and alliances as strategies to keep their market share. For instance, Stratasys said the J3 DentaJet 3D printer would go on sale in February 2023. With the help of this printer, dental laboratories may quickly manufacture very precise mixed uses for a single tray. Additionally, in November 2021, Stratasys joined forces with RICOH 3D for Health to use its 3D printing technology to offer hospitals and additional medical professionals’ patient-specific anatomic models. '3D Systems Corporation (USA) ', 'Stratasys Ltd. (USA) ', 'Materialise NV (Belgium) ', 'GE Additive (USA) ', 'Stryker Corporation (USA) ', 'Renishaw plc (UK) ', 'EnvisionTEC GmbH (Germany) ', 'EOS GmbH (Germany) ', 'SLM Solutions Group AG (Germany) ', 'Carbon, Inc. (USA) ', 'Organovo Holdings, Inc. (USA) ', 'Prodways Group (France) ', 'Arcam AB (Sweden) ', 'Concept Laser GmbH (Germany) ', 'Formlabs (USA) ', 'HP Inc. (USA) ', 'Proto Labs, Inc. (USA) ', 'Voxeljet AG (Germany) ', 'Nano Dimension (Israel)'

The healthcare additive manufacturing market is driven by continuous advancements in additive manufacturing technologies, such as 3D printing. These technologies enable the production of complex and customized medical devices, implants, and anatomical models, leading to improved patient outcomes and personalized healthcare solutions.

Increasing Adoption of Metal Additive Manufacturing: There is a growing trend of adopting metal additive manufacturing technologies in the healthcare sector. Metal 3D printing allows for the production of implants, prosthetics, and surgical instruments with excellent mechanical properties and biocompatibility. This trend is driven by advancements in metal 3D printing technologies and the increasing demand for patient-specific implants.

North America dominated the medical additive production market in 2023 with a 38.1% revenue share. The key forces behind regional expansion in the United States and Canada are the rise in the older population, considerable spending power, solid government backing for excellent healthcare, and attractive reimbursement standards.